25/06/2026
Gabapentin is a narrow-spectrum agent against focal seizures. It may cause
exacerbation of myoclonus. It is also FDA approved for the treatment of
postherpetic neuralgia. An extended-release preparation (gabapentin enacarbil)
has been approved for the treatment of restless legs syndrome, and another
(gastroretentive dosage form) has been approved for the management of
postherpetic neuralgia.